Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0%
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Lotus Pharmaceuticals, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
3 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| LIU ZHONGYI | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jin Liu | Sell | $4.8K | SEC |
| ROTHBERG MELVIN | Other | $30K | SEC |
| ROTHBERG MELVIN | Sell | $30.3K | SEC |
| WASSERMAN ADAM C | Other | $27.5K | SEC |
| WASSERMAN ADAM C | Other | $44.2K | Unusual size | SEC |
| GENESIS TECHNOLOGY GROUP INC | Other | n/a (No price was disclosed in the filing) | SEC |
| GENESIS TECHNOLOGY GROUP INC | Sell | $374K | SEC |